ImmusanT, a biotechnology company out of Massachusetts is working on developing Nexxax2, a vaccine which could potentially treat or prevent celiac disease. As of this week, they finished the Phase 1 b trial. This means that we are now closer than ever to finding some sort of “cure” or treatment for celiac beyond the dietary […]
Chloe graduated from UMaine Orono with a BA in Mass Communication and a minor in Political Science. In addition to writing for the BDN, she has been Editor in Chief of Her Campus UMaine, Contributing Editor of Odyssey UMaine, and a Staff Writer for The Maine Campus . She has known about her Celiac Disease for about two years and has been eating gluten free as well as sometimes dairy free. She is from Chebeague Island, Maine, where she grew up, but has also lived in Cleveland, Ohio, and Blagoevgrad, Bulgaria in addition to Orono.